For the quarter ending 2025-09-30, KRMD had $409,303 increase in cash & cash equivalents over the period. $12,973 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -777,965 | -1,373,105 |
| Loss on disposal of fixed assets | - | 0 |
| Stock-based compensation expense and warrant expense | 627,393 | 1,113,334 |
| Depreciation and amortization | 204,482 | 426,844 |
| Accounts receivable | 482,930 | -791,679 |
| Inventory | 463,867 | 1,144,174 |
| Prepaid expenses and other assets | 483,850 | -379,330 |
| Other liabilities | -101,212 | 74,833 |
| Accounts payable | 777,623 | -555,430 |
| Accrued payroll and related taxes | -232,876 | -122,459 |
| Non-cash lease adjustments | - | 0 |
| Accrued expenses | 998,658 | -288,659 |
| Net cash used in operating activities | 65,456 | -697,807 |
| Purchases of property and equipment | 52,483 | 472,252 |
| Purchases of intangible assets | 0 | 3,400 |
| Net cash used in investing activities | -52,483 | -475,652 |
| Proceeds from exercise of employee stock options | 89,025 | - |
| Borrowings from insurance finance indebtedness | 677,903 | -271,152 |
| Payments on insurance finance indebtedness | -342,972 | - |
| Payments on finance lease liability | 27,626 | 54,084 |
| Payments for taxes related to net share settlement of equity awards | 0 | 27,536 |
| Net cash provided by (used in) financing activities | 396,330 | -352,772 |
| Net decrease in cash and cash equivalents | 409,303 | -1,526,231 |
| Cash and cash equivalents at beginning of period | 9,580,947 | - |
| Cash and cash equivalents at end of period | 8,464,019 | - |
KORU Medical Systems, Inc. (KRMD)
KORU Medical Systems, Inc. (KRMD)